Mechanisms of Retinal Vascular Permeability in Diabetes
Mechanisms of Retinal Vascular Permeability in Diabetes
批准号:
10701684
负责人:
David Antonetti
金额:
$45.16万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-09-01 至 2025-07-31
关键词:
AdultAgeBindingBiological ProductsBiologyBlindnessBlood VesselsBlood capillariesBlood-Retinal BarrierCell Culture TechniquesCell FractionationCell membraneCollaborationsComplexContrast SensitivityDataDevelopmentDiabetes MellitusDiabetic RetinopathyDiseaseEdemaElementsEndophthalmitisEndothelial CellsEndotheliumEnvironmentGene DeletionGenesGoalsHealthInflammatoryInjectionsInjuryIschemiaLasersLight CoagulationLinkLondonMaintenanceMediatingMembraneModelingMolecularMusMutation AnalysisNational Eye InstituteNatural regenerationNeural RetinaNeurogliaOnset of illnessPathologicPathway interactionsPatientsPermeabilityProcessPropertyProteinsRattusRegulationResearchResistanceRetinaRetinal DiseasesRiskRobin birdRoleSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNATestingTherapeuticTight JunctionsTranscriptional ActivationTransgenic OrganismsUnited StatesUniversitiesVascular DiseasesVascular Endothelial Growth FactorsVascular EndotheliumVascular PermeabilitiesViral VectorVisionVisual AcuityWNT Signaling PathwayWorld Health Organizationadeno-associated viral vectorangiogenesiscofactorcollegecytokineepidemiologic datagene replacementin vivoinhibitorinsightmacular edemanovelnovel therapeuticspreservationpreventprotein expressionreceptorrepairedrestorationretina blood vessel structureretinal damagesolutetemporal measurement
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Diabetes mellitus remains a leading cause of blindness world-wide and epidemiological data
from the World Health Organization reveal over 422 million adults live with diabetes and the rate
of disease onset continues to rise. According to the National Eye Institute 10.2 million US adults
40 years and older have diabetes mellitus, and 8.2% with vision threatening retinopathy.
Macular edema remains closely linked to loss of vision and current therapies focus on
mechanisms to prevent cytokine driven changes in vascular permeability that promote edema.
Our previous research has fundamentally contributed to understanding the molecular
mechanisms that lead to vascular endothelial growth factor (VEGF) induced retinal vessel
permeability. The development of effective anti-VEGF therapies has been a welcome addition
for the treatment of diabetic retinopathy, but this approach remains insufficient and new
therapies are needed. In the current application we now focus on understanding the process of
blood-retinal barrier regeneration. Research has identified a required role for norrin in formation
of the blood-retinal barrier. Here, we explore the exciting potential for norrin to restore vascular
barrier properties after VEGF-induced injury. The studies promise to shed new light on how
these two critical cytokines interact to control retinal vessel barrier properties. Further,
preliminary data reveal completely novel interactions of the norrin signaling molecule,
disheveled (DVL), binding directly to tight junction proteins. The role of these protein interactions
on norrin signaling and tight junction biology will be elucidated at a molecular level in order to
understand the mechanisms of norrin action on barrier restoration. We expect this proposal will
provide novel information on regulation of the blood-retinal barrier in health and in diabetes and
will provide a framework from which to develop potential new therapeutic options to treat
macular edema.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Isolation and characterization of retinal endothelial cells.
视网膜内皮细胞的分离和表征。
DOI:
10.1385/1-59259-419-0:365
发表时间:
2003
期刊:
Methods in molecular medicine.
影响因子:
--
作者:
[Antonetti,DavidA, Wolpert,EllenB]
通讯作者:
Wolpert,EllenB
DOI:
10.1021/pr7007913
发表时间:
2009-02
期刊:
JOURNAL OF PROTEOME RESEARCH
影响因子:
4.4
作者:
[Sundstrom, Jeffrey M., Tash, Brian R., Murakami, Tomoaki, Flanagan, John M., Bewley, Maria C., Stanley, Bruce A., Gonsar, Kristin B., Antonetti, David A.]
通讯作者:
Antonetti, David A.
DOI:
10.1371/journal.pone.0018076
发表时间:
2011-03-25
期刊:
PloS one
影响因子:
3.7
作者:
[Cai J, Wu L, Qi X, Shaw L, Li Calzi S, Caballero S, Jiang WG, Vinores SA, Antonetti D, Ahmed A, Grant MB, Boulton ME]
通讯作者:
Boulton ME
DOI:
10.1042/bj20111961
发表时间:
2012-09-15
期刊:
The Biochemical journal
影响因子:
--
作者:
[Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, Antonetti DA]
通讯作者:
Antonetti DA
DOI:
10.2337/db12-1744
发表时间:
2013-06
期刊:
Diabetes
影响因子:
7.7
作者:
[Titchenell PM, Antonetti DA]
通讯作者:
Antonetti DA
共 17 条
The role of heme in retinal vascular development and disease
-
批准号:10568168
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2023
-
负责人:David Antonetti
-
依托单位:
Leica SP8 Confocal Microscope
-
批准号:10175244
-
项目类别:
-
资助金额:$59.91万
-
财政年份:2021
-
负责人:David Antonetti
-
依托单位:
Discovering novel atypical PKC inhibitors as in vivo chemical probes - Supplement to Promote Diversity
-
批准号:9196555
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2016
-
负责人:David Antonetti
-
依托单位:
Induction of the blood-retinal barrier
-
批准号:8174090
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2009
-
负责人:David Antonetti
-
依托单位:
Induction of the blood-retinal barrier
-
批准号:7572450
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2009
-
负责人:David Antonetti
-
依托单位:
Induction of the blood-retinal barrier
-
批准号:7747982
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2009
-
负责人:David Antonetti
-
依托单位:
Drug Discovery for Diabetic Retinopathy
-
批准号:6826317
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2004
-
负责人:David Antonetti
-
依托单位:
Drug Discovery for Diabetic Retinopathy
-
批准号:6948454
-
项目类别:
-
资助金额:$26.2万
-
财政年份:2004
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:10219254
-
项目类别:
-
资助金额:$43.81万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:7220571
-
项目类别:
-
资助金额:$32.49万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8460893
-
项目类别:
-
资助金额:$40.64万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8989102
-
项目类别:
-
资助金额:$42.93万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:7390273
-
项目类别:
-
资助金额:$31.7万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8288268
-
项目类别:
-
资助金额:$36.68万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:9198225
-
项目类别:
-
资助金额:$42.93万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8462825
-
项目类别:
-
资助金额:$6.11万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:6889188
-
项目类别:
-
资助金额:$33.74万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8206694
-
项目类别:
-
资助金额:$36.65万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8792477
-
项目类别:
-
资助金额:$43.0万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
Mechanisms of Retinal Vascular Permeability in Diabetes
-
批准号:8166420
-
项目类别:
-
资助金额:$21.54万
-
财政年份:1998
-
负责人:David Antonetti
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: